Andor and Akoya Biosciences have announced they will collaborate in the “spatial omics” market

Date Announced: 16 Sep 2021

Under the partners’ agreement the companies will support their mutual user base within Akoya’s Imaging Innovators (I²) Network.

Andor Dragonfly high-speed confocal products combined with Akoya’s Codex solution delivers “outstanding data quality for hi-plex 3D tissue imaging, deepening scientific insights and diagnostic potential,” say the partners.

Andrew Dennis, Director of Product Management at Andor, added, “In this collaboration with Akoya our goal is to deliver high quality data and service for bio-discovery. Andor’s high-speed confocal instruments are established performance leaders and, with Codex, will help to deepen our contribution to spatial proteomics. We are delighted to work with Akoya as a leader in the field.”

Hi-plex 3D tissue imaging enables “spatial omics”, by iteratively multiplexing molecular labelling and tissue scanning technologies. Analysis of the resulting data sets provides high-resolution protein or mRNA maps at the sub-cellular level for dozens or even hundreds of target molecules.

Armed with this knowledge researchers can map gene (transcriptome) and protein (proteome) activity in a tissue sample. Due to its innovative approach and the range of expected applications, Spatial Transcriptomics was selected as “Method of the year 2020” by Nature Methods journal. Applications range from speeding up discovery in basic science to predicting disease pathology, progression, and treatment response.

Contact

E-mail: marketing@andor.com

Web Site: https://www.andor.oxinst.com